515 related articles for article (PubMed ID: 8281671)
1. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy.
Gurbel PA; Anderson RD; MacCord CS; Scott H; Komjathy SF; Poulton J; Stafford JL; Godard J
Circulation; 1994 Jan; 89(1):361-5. PubMed ID: 8281671
[TBL] [Abstract][Full Text] [Related]
2. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
[TBL] [Abstract][Full Text] [Related]
3. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent.
Prewitt RM; Gu S; Schick U; Ducas J
J Am Coll Cardiol; 1994 Mar; 23(3):794-8. PubMed ID: 8113566
[TBL] [Abstract][Full Text] [Related]
4. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
Przyklenk K; Kloner RA
Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
[TBL] [Abstract][Full Text] [Related]
5. Increase in coronary blood flow by intra-aortic balloon counterpulsation in a porcine model of myocardial reperfusion.
Bonios MJ; Pierrakos CN; Argiriou M; Dalianis A; Terrovitis JV; Dolou P; Drakos SG; Koudoumas D; Charitos CE; Anastasiou-Nana MI
Int J Cardiol; 2010 Feb; 138(3):253-60. PubMed ID: 18805599
[TBL] [Abstract][Full Text] [Related]
6. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model.
Smalling RW; Cassidy DB; Barrett R; Lachterman B; Felli P; Amirian J
Circulation; 1992 Mar; 85(3):1152-9. PubMed ID: 1537113
[TBL] [Abstract][Full Text] [Related]
7. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy.
Kono T; Morita H; Nishina T; Fujita M; Onaka H; Hirota Y; Kawamura K; Fujiwara A
J Am Coll Cardiol; 1996 Oct; 28(4):876-81. PubMed ID: 8837563
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.
Biemond BJ; Levi M; Coronel R; Janse MJ; ten Cate JW; Pannekoek H
Circulation; 1995 Feb; 91(4):1175-81. PubMed ID: 7850956
[TBL] [Abstract][Full Text] [Related]
9. Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.
Nicolini FA; Nichols WW; Saldeen TG; Mehta JL
Cardiovasc Res; 1991 Apr; 25(4):283-9. PubMed ID: 1909212
[TBL] [Abstract][Full Text] [Related]
10. Enhanced coronary flow velocity during intra-aortic balloon pumping assessed by transthoracic Doppler echocardiography.
Takeuchi M; Nohtomi Y; Yoshitani H; Miyazaki C; Sakamoto K; Yoshikawa J
J Am Coll Cardiol; 2004 Feb; 43(3):368-76. PubMed ID: 15013116
[TBL] [Abstract][Full Text] [Related]
11. Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study.
Pierrakos CN; Bonios MJ; Drakos SG; Charitos EI; Tsolakis EJ; Ntalianis A; Nanas SN; Charitos CE; Nanas JN; Terrovitis JV
Artif Organs; 2011 Sep; 35(9):867-74. PubMed ID: 21726241
[TBL] [Abstract][Full Text] [Related]
12. The effect of intra-aortic balloon counterpulsation on coronary blood flow velocity distal to coronary artery stenoses.
Anderson RD; Gurbel PA
Cardiology; 1996; 87(4):306-12. PubMed ID: 8793165
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive therapy with low molecular weight heparin with recombinant tissue-type plasminogen activator causes sustained reflow in canine coronary thrombosis.
Nicolini FA; Nichols WW; Saldeen TG; Khan S; Mehta JL
Am Heart J; 1992 Aug; 124(2):280-8. PubMed ID: 1322029
[TBL] [Abstract][Full Text] [Related]
14. The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study.
Azevedo CF; Amado LC; Kraitchman DL; Gerber BL; Edvardsen T; Osman NF; Rochitte CE; Wu KC; Lima JA
Eur Heart J; 2005 Jun; 26(12):1235-41. PubMed ID: 15716282
[TBL] [Abstract][Full Text] [Related]
15. [Intra-aortic balloon pumping and variations in flow in the dilated coronary artery in acute myocardial infarction].
Prunier F; Furber A; Delépine S; Merheb M; Geslin P
Arch Mal Coeur Vaiss; 2003 Apr; 96(4):317-23. PubMed ID: 12741308
[TBL] [Abstract][Full Text] [Related]
16. Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion.
Rebello SS; Huang J; Saito K; Saucedo JF; Bates ER; Lucchesi BR
Eur J Pharmacol; 1999 Jun; 374(3):399-410. PubMed ID: 10422784
[TBL] [Abstract][Full Text] [Related]
17. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
Sitko GR; Ramjit DR; Stabilito II; Lehman D; Lynch JJ; Vlasuk GP
Circulation; 1992 Feb; 85(2):805-15. PubMed ID: 1735171
[TBL] [Abstract][Full Text] [Related]
18. Intravenous administration of recombinant tissue plasminogen activator. Optimizing the rate of coronary thrombolysis.
Prewitt RM; Gu S; Schick U; Ducas J
Chest; 1995 Apr; 107(4):1146-51. PubMed ID: 7705128
[TBL] [Abstract][Full Text] [Related]
19. Enhanced myocardial salvage by maintenance of microvascular patency following initial thrombolysis with recombinant tissue plasminogen activator.
Longridge DJ; Follenfant MJ; Maxwell MP; Ford AJ; Hughes B
Cardiovasc Res; 1990 Sep; 24(9):697-706. PubMed ID: 2121357
[TBL] [Abstract][Full Text] [Related]
20. Single bolus administration of recombinant tissue plasminogen activator: effects on infarct related vessel patency, microvascular perfusion, and microvascular reocclusion in a canine model of thrombotic occlusion/reperfusion.
Longridge DJ; Follenfant MJ; Ford AJ
Cardiovasc Res; 1991 Mar; 25(3):184-91. PubMed ID: 1903080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
